Page last updated: 2024-08-26

sr141716 and Cardiovascular Stroke

sr141716 has been researched along with Cardiovascular Stroke in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (85.71)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baulmann, J; Grzesiak, A; Kappert, K; Kaschina, E; Kemnitz, UR; Kintscher, U; Lauer, D; Paulis, L; Slavic, S; Sommerfeld, M; Thöne-Reineke, C; Trappiel, M; Unger, T	1
Davidson, SM; Lim, SY; Smith, CC; Yellon, DM	1
Bernatskaia, NA; Krylatov, AV; Maslov, LN; Mechoulam, R; Pertwee, RG; Sal'nikova, OM; Sharaevskiĭ, MA; Stefano, GB	1
Arnaud, C; Demenge, P; Godin-Ribuot, D; Joyeux, M; Lamontagne, D; Ribuot, C	1
Bouchard, JF; Lagneux, C; Lamontagne, D; Lépicier, P	1
Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N; Ghosh, J; Kaye, GC; Nasir, M	1
Berry, C; Bourassa, MG	1

Reviews

1 review(s) available for sr141716 and Cardiovascular Stroke

Article	Year
Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. European journal of heart failure, 2004, Volume: 6, Issue:4 Topics: Anticoagulants; Cardiology; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Meta-Analysis as Topic; Myocardial Infarction; Pacemaker, Artificial; Piperidines; Platelet Aggregation Inhibitors; Pyrazoles; Rimonabant; United States; Warfarin	2004

Article

Year

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure.

European journal of heart failure, 2004, Volume: 6, Issue:4

Topics: Anticoagulants; Cardiology; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Meta-Analysis as Topic; Myocardial Infarction; Pacemaker, Artificial; Piperidines; Platelet Aggregation Inhibitors; Pyrazoles; Rimonabant; United States; Warfarin

2004

Other Studies

6 other study(ies) available for sr141716 and Cardiovascular Stroke

Article	Year
Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome. Journal of molecular medicine (Berlin, Germany), 2013, Volume: 91, Issue:7 Topics: Animals; Cannabinoid Receptor Antagonists; Cardiotonic Agents; Cells, Cultured; Collagen; Fibroblasts; Heart; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metabolic Syndrome; Myocardial Infarction; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Transforming Growth Factor beta1	2013
The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction. Basic research in cardiology, 2009, Volume: 104, Issue:6 Topics: Adiponectin; Animals; Blotting, Western; Diet, Atherogenic; Dietary Fats; Enzyme-Linked Immunosorbent Assay; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant	2009
[Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2002, Volume: 88, Issue:5 Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Camphanes; Cannabinoids; Coronary Artery Disease; Dronabinol; Epinephrine; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant	2002
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts. Cardiovascular research, 2002, Aug-15, Volume: 55, Issue:3 Topics: Analysis of Variance; Animals; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Endocannabinoids; Fever; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Time Factors	2002
Endocannabinoids protect the rat isolated heart against ischaemia. British journal of pharmacology, 2003, Volume: 139, Issue:4 Topics: Amides; Animals; Arachidonic Acids; Biomarkers; Blotting, Western; Camphanes; Cannabinoid Receptor Modulators; Endocannabinoids; Ethanolamines; Glycerides; Heart; Imidazoles; L-Lactate Dehydrogenase; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; p38 Mitogen-Activated Protein Kinases; Palmitic Acids; Piperidines; Protein Kinase C; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Rimonabant; Signal Transduction	2003
Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes. Current atherosclerosis reports, 2008, Volume: 10, Issue:2 Topics: Antihypertensive Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Diabetic Angiopathies; Humans; Hyperglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Life Style; Myocardial Infarction; Obesity; Pioglitazone; Piperidines; Platelet Aggregation Inhibitors; Prediabetic State; Pyrazoles; Ramipril; Rimonabant; Risk Assessment; Thiazolidinediones; Triglycerides; Weight Loss	2008